z-logo
open-access-imgOpen Access
Is CC Chemokine Ligand 17 (TARC) Driving Disease Progression in Chronic Obstructive Pulmonary Disease?
Author(s) -
Jason Girkin
Publication year - 2022
Publication title -
american journal of respiratory cell and molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.469
H-Index - 161
eISSN - 1535-4989
pISSN - 1044-1549
DOI - 10.1165/rcmb.2021-0518ed
Subject(s) - pulmonary disease , chemokine , medicine , immunology , chemokine receptor , ligand (biochemistry) , inflammation , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here